Revenue: The sum of all revenue fields included for a company's operating activities.
Phio Pharmaceuticals Corp. (PHIO) Revenue data is not available for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-1.90M |
|
-- |
|
-- |
|
$1.90M |
|
$-1.90M |
|
-- |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.90M |
|
$-1.89M |
|
2.08M |
|
2.08M |
|
$0.56 |
|
$0.56 |
|
| Balance Sheet Financials | |
$9.32M |
|
$0.01M |
|
$0.04M |
|
$9.36M |
|
$1.63M |
|
-- |
|
-- |
|
$1.63M |
|
$7.73M |
|
$7.73M |
|
$7.73M |
|
3.75M |
|
| Cash Flow Statement Financials | |
$-10.75M |
|
$-0.01M |
|
$7.41M |
|
$11.83M |
|
$8.49M |
|
$-3.34M |
|
$0.30M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.59% |
|
-24.59% |
|
-20.30% |
|
-24.59% |
|
$2.06 |
|
$-5.16 |
|
$-5.16 |
|